Organ Failure, Multiple Clinical Trial
— IN-PANCIAOfficial title:
Clinical Evaluation of Gastro Intestinal Failure, Multiple Organ Failure and Levels of Citrulline in Critical Ill Patients
The gastrointestinal dysfunction occurs frequently during the intensive care unit (ICU) stay
and is associated with a worse prognosis.
The gastrointestinal failure (GIF) is diagnosed based on symptoms such as bowel distension,
ileus, diarrhea, digestive bleeding, or intestinal ischemia. A GIF score based on has been
demonstrated to be correlated with outcome, with higher scores indicating higher risk of
death. However, GIF may be occult or clinical signs can go undetected in critically ill
patients due to the frequent use of analgesic, sedative or neuromuscular blocking agents,
acute neurologic diseases, or delirium.
Citrulline is a potential biomarker for small bowel function in critically ill patients with
maintained renal function. Normal plasma citrulline levels (12-55 µmol/L) are determined by
the balance between gut synthesis and kidney degradation.
GIF is involved in the pathogenesis of multiple organ dysfunctions and failures (MOF)
through various mechanisms, and it is often associated with high intra-abdominal pressure
(IAP). IAP greater than 12 mmHg, may lead to abdominal compartment syndrome (ACS) and MOF,
including cardiac, respiratory and kidney failure. Studies have suggested that GIF can be
the consequence rather than the cause of MOF.
The aim of this study is to investigate if plasma citrulline levels is associated with a
clinical diagnosis of GIF, and may predict the development of MOF.
Status | Completed |
Enrollment | 42 |
Est. completion date | July 2015 |
Est. primary completion date | July 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Intensive Care Unit stay of at least 48 hours Exclusion Criteria: - Intensive Care Unit stay less than 48 hours - abdominal trauma or surgery in the last 6 weeks - inflammatory bowel disease - a body mass index (BMI) =35 - terminal condition. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Azienda Ospedaliera Spedali Civili di Brescia | Università degli Studi di Brescia |
Carlson GL, Dark P. Acute intestinal failure. Curr Opin Crit Care. 2010 Aug;16(4):347-52. doi: 10.1097/MCC.0b013e328339fabe. Review. — View Citation
Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D'Amours S, Wendon J, Hillman K, Johansson K, Kolkman K, Wilmer A. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Med. 2006 Nov;32(11):1722-32. Epub 2006 Sep 12. — View Citation
Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011 Jun;37(6):911-7. doi: 10.1007/s00134-011-2172-x. Epub 2011 Mar 12. Review. — View Citation
Piton G, Manzon C, Monnet E, Cypriani B, Barbot O, Navellou JC, Carbonnel F, Capellier G. Plasma citrulline kinetics and prognostic value in critically ill patients. Intensive Care Med. 2010 Apr;36(4):702-6. doi: 10.1007/s00134-010-1751-6. — View Citation
Puleo F, Arvanitakis M, Van Gossum A, Preiser JC. Gut failure in the ICU. Semin Respir Crit Care Med. 2011 Oct;32(5):626-38. doi: 10.1055/s-0031-1287871. Epub 2011 Oct 11. Review. — View Citation
Reintam A, Parm P, Kitus R, Starkopf J, Kern H. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12(4):R90. doi: 10.1186/cc6958. Epub 2008 Jul 14. Erratum in: Crit Care. 2008;12(6):435. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Development of Gastro Intestinal Failure, defined as the presence of three or more gastro-intestinal symptoms; and Multiple Organ Failure measured by SOFA score | to investigate if plasma citrulline levels are associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. Gastrointestinal Failure is defined as the presence of three or more coincident GI symptoms (igh gastric residual volumes (GRV) = maximum GRV above 500 ml at least once. Absent bowel sounds (BS) = BS not heard on careful auscultation. Vomiting/Regurgitation= visible vomiting or regurgitation in any amount. Diarrhoea = loose of liquid stool three or more times per day. Bowel distension= suspected or radiologically confirmed bowel dilatation in any bowel segment. GI bleeding= visible appearance of blood in vomit, nasogastric aspirate or stool.). MOF was defined as the failure of two or more organs or system according to the Sequential Organ Failure Assessment (SOFA) | within the first 30 days after admission in intensive care unit | Yes |
Secondary | Correlation between intra abdominal hypertension (defined as an average of intra-abdominal pressure of the day = 12 mmHg), and development of Gastro Intestinal Failure and Multiple Organ Failure | to investigate if increasing of intra abdominal pressure is associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. Intra-abdominal Hypertension (IAH) is defined as an average IAP of the day = 12 mmHg; abdominal compartment syndrome (ACS) is defined as a sustained (minimally two standardized measurements, performed 1-6 h apart) increase in IAP above 20 mmHg with new onset organ failure. | within the first 30 days after admission in intensive care unit | Yes |
Secondary | Correlation between levels of Arginine and Glutamine in patients with Gastro Intestinal Failure and Multiple Organ Failure | to investigate if plasma Arginine and Glutamine levels are associated with a clinical diagnosis of Gastro Intestinal Failure, and may predict the development of Multiple Organ Failure. | within the first 30 days after admission in intensive care unit | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04695119 -
Sepsis in the ICU-II
|
||
Not yet recruiting |
NCT05872152 -
Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs
|
N/A | |
Not yet recruiting |
NCT04502511 -
Heterogeneity of Critical Illness: a Cohort Study
|
||
Recruiting |
NCT03825250 -
The Val-CARD Trial
|
Phase 1/Phase 2 | |
Completed |
NCT03344627 -
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
|
N/A | |
Completed |
NCT04772703 -
DNA Damage in Critically Ill COVID-19 Patients
|
||
Recruiting |
NCT06452966 -
The Impact and Effect of Traditional Chinese Medicine Treatment on Organ Failure in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04015973 -
The PRE-OP ENERGY Trial
|
N/A | |
Withdrawn |
NCT03933930 -
Comparing the Prognosis of Lactate-directed and Goal-directed Therapy in Hyperthermic Intraperitoneal Chemotherapy.
|
N/A | |
Completed |
NCT03075605 -
PROOF: Pancreatitis-associated Risk Of Organ Failure
|
||
Not yet recruiting |
NCT06330610 -
Evaluation of the Efficiency of Intermittent Enteral Nutrition on Multi-organ Failure From Patients With Mechanical Ventilation in Intensive Care Unit
|
N/A | |
Recruiting |
NCT03547232 -
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial)
|
Phase 4 | |
Not yet recruiting |
NCT03282253 -
Elevated Stearoyl-CoA Desaturase-1 Expression Predicts the Disease Severity of Severe Acute Pancreatitis
|
N/A | |
Completed |
NCT05972980 -
Ventilator-Associated Pneumonia in Critically Ill COVID-19 vs. Non-COVID-19 Patients
|
||
Withdrawn |
NCT03167788 -
Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery
|
Phase 2 | |
Recruiting |
NCT05405426 -
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
|
N/A | |
Completed |
NCT04732481 -
Evaluation of Corrected Carotid Flow Time Variations During Passive Leg Lift to Predict Response to Filling.
|